The emerging approach of the medication represents a major development in the management of type 2 diabetes. Unlike existing medications, tirzepatide targets two pathways – GLP-1 and glucose-dependent insulinotropic https://tirzepatide-peptide347334.bloggip.com/42531067/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment